Mónica Ortegón

Cost-Effectiveness of Prevention and Treatment of the Diabetic Foot

Mónica Ortegón, Ken Redekop, Louis Niessen · Diabetes Care · 2004 · 190 citations · Full text

Pharmacy, Pharmacoeconomics, Preventive Medicine +17

Prediction of Coronary Heart Disease Risk in a General, Pre-Diabetic, and Diabetic Population During 10 Years of Follow-up: Accuracy of the Framingham, SCORE, and UKPDS Risk Functions

Amber A. van der Heijden, Mónica Ortegón, Louis Niessen et al. · Diabetes Care · 2009 · 109 citations · Full text

Medicine, Biostatistics, Cardiology +17

Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study

Mónica Ortegón, S. Lim, Dan Chisholm et al. · BMJ · 2012 · 105 citations · Full text

Pharmacy, Chronic Disease Prevention, Pharmacoeconomics +17

Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study

Anderson Stanciole, Mónica Ortegón, Dan Chisholm et al. · BMJ · 2012 · 66 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17

What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia?

Dan Chisholm, Rob Baltussen, David Evans et al. · BMJ · 2012 · 31 citations

Medicine, Health Policy, Infectious Disease Control +15